Chronic Leukemia — Trials

Chronic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 207
Ph III recruiting: 22
Growth YoY: −13.3%
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 51–100 of 818 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01885689	Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia	active not recruiting	Phase 2	72	City of Hope Medical CenterOTHER	1	Aug 27, 2026	clinicaltrials
NCT06523556	Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia	recruiting	Phase 1 / Phase 2	49	Uma BorateOTHER